| Marna J Atkinson, CRNA | |
|
550 N Hillside St, Wichita, KS 67214-4910 | |
| (316) 962-3030 | |
| Not Available |
| Full Name | Marna J Atkinson |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 29 Years |
| Location | 550 N Hillside St, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083606271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 54451 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wesley Medical Center | Wichita, KS | Hospital |
| Rock Regional Hospital, Llc | Derby, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wichita Anesthesiology Chartered | 4587577796 | 70 |
News Archive
Atlas Genetics Ltd, the ultra-rapid 'test and treat' molecular diagnostics company, today announces that it has entered into a collaboration with a major pharmaceutical company to develop a diagnostic test, expanding capabilities beyond infectious diseases.
Thanks to our ability to learn and to remember, we can perform tasks that other living things can not even dream of.
A $12 million federal grant enabled City of Hope and collaborators to deploy a novel cloud-computing platform, making an immense amount of data from a historic 25-year study more accessible and user-friendly.
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
› Verified 4 days ago
| Entity Name | Wichita Anesthesiology Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407848450 PECOS PAC ID: 4587577796 Enrollment ID: O20031112000357 |
News Archive
Atlas Genetics Ltd, the ultra-rapid 'test and treat' molecular diagnostics company, today announces that it has entered into a collaboration with a major pharmaceutical company to develop a diagnostic test, expanding capabilities beyond infectious diseases.
Thanks to our ability to learn and to remember, we can perform tasks that other living things can not even dream of.
A $12 million federal grant enabled City of Hope and collaborators to deploy a novel cloud-computing platform, making an immense amount of data from a historic 25-year study more accessible and user-friendly.
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marna J Atkinson, CRNA 8080 E Central Ave, Ste 250, Wichita, KS 67206-2361 Ph: (316) 686-7327 | Marna J Atkinson, CRNA 550 N Hillside St, Wichita, KS 67214-4910 Ph: (316) 962-3030 |
News Archive
Atlas Genetics Ltd, the ultra-rapid 'test and treat' molecular diagnostics company, today announces that it has entered into a collaboration with a major pharmaceutical company to develop a diagnostic test, expanding capabilities beyond infectious diseases.
Thanks to our ability to learn and to remember, we can perform tasks that other living things can not even dream of.
A $12 million federal grant enabled City of Hope and collaborators to deploy a novel cloud-computing platform, making an immense amount of data from a historic 25-year study more accessible and user-friendly.
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
› Verified 4 days ago
Jaysa L Nichols, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave, Suite 250, Wichita, KS 67206 Phone: 316-686-7327 Fax: 316-858-1556 | |
George Findley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave Ste 250, Wichita, KS 67206 Phone: 316-461-4497 Fax: 316-686-1557 | |
Jill C Gallagher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8330 E Overbrook St, Wichita, KS 67206 Phone: 316-644-1193 | |
Janet L Miller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3450 N Rock Rd Ste 208, Wichita, KS 67226 Phone: 316-685-6091 | |
Seth Claassen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8080 E Central Ave Ste 250, Wichita, KS 67206 Phone: 316-686-7327 Fax: 316-686-1557 | |
Wade Frederick Winter, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 929 N Saint Francis Ave, Wichita, KS 67214 Phone: 316-268-5000 Fax: 316-291-4272 | |
Mr. Brian Lee Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6615 Briarwood Cir, Wichita, KS 67212 Phone: 316-729-4474 Fax: 316-729-4474 |